We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

47 hedge funds and large institutions have $50M invested in Tonix Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

487% more capital invested

Capital invested by funds: $8.53M → $50M (+$41.5M)

350% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 6

81% more funds holding

Funds holding: 26 → 47 (+21)

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

11.34% more ownership

Funds ownership: 7.56% → 18.9% (+11%)

Holders
47
Holders Change
+21
Holders Change %
+80.77%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
10
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$9.19M
2
Northern Trust
Northern Trust
Illinois
+$3.96M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.97M
4
State Street
State Street
Massachusetts
+$2.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.92M

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$878K
2
Millennium Management
Millennium Management
New York
-$733K
3
HF
HRT Financial
New York
-$486K
4
CIAM
Caitong International Asset Management
Hong Kong
-$405K
5
VF
Virtu Financial
New York
-$302K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$15.1M +$9.19M +350,868 +504%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$6.31M +$2.97M +113,175 +182%
Vanguard Group
3
Vanguard Group
Pennsylvania
$5.93M +$1.92M +73,236 +80%
Northern Trust
4
Northern Trust
Illinois
$5.9M +$3.96M +150,954 +1,155%
State Street
5
State Street
Massachusetts
$4.43M +$2.7M +103,204 +515%
N
6
Nuveen
North Carolina
$1.87M +$1.36M +51,892 New
SPS
7
Susquehanna Portfolio Strategies
Pennsylvania
$1.49M +$1.09M +41,454 New
UBS Group
8
UBS Group
Switzerland
$808K +$65.3K +2,494 +12%
Charles Schwab
9
Charles Schwab
California
$782K +$569K +21,732 New
Morgan Stanley
10
Morgan Stanley
New York
$681K +$426K +16,251 +607%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$639K +$465K +17,748 New
CIBC Asset Management
12
CIBC Asset Management
Ontario, Canada
$632K – – –
Barclays
13
Barclays
United Kingdom
$478K +$348K +13,299 New
AllianceBernstein
14
AllianceBernstein
Tennessee
$470K +$342K +13,070 New
Fidelity Investments
15
Fidelity Investments
Massachusetts
$459K +$334K +12,753 New
RhumbLine Advisers
16
RhumbLine Advisers
Massachusetts
$406K -$62.2K -2,372 -17%
EH
17
Equitable Holdings
New York
$379K -$117K -4,475 -30%
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$324K +$236K +9,008 New
Millennium Management
19
Millennium Management
New York
$319K -$733K -27,984 -76%
TRCT
20
Tower Research Capital (TRC)
New York
$258K +$97.8K +3,731 +108%
Citadel Advisors
21
Citadel Advisors
Florida
$255K +$185K +7,077 New
State Board of Administration of Florida Retirement System
22
State Board of Administration of Florida Retirement System
Florida
$249K +$181K +6,916 New
JSL
23
JT Stratford LLC
Georgia
$232K +$169K +6,441 New
Deutsche Bank
24
Deutsche Bank
Germany
$185K +$135K +5,138 New
Wells Fargo
25
Wells Fargo
California
$175K +$127K +4,856 New
1
2 3

TNXP Hedge Fund Activity: Q2 2025 in Review

47 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q2 2025, worth a combined $50M — up 487% from $8.53M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new TNXP positions and 6 closed out — a net gain of 21 holders — while 10 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, adding an estimated $9.19M. The largest seller was Royal Bank of Canada, cutting an estimated $878K.

  • 47 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q2 2025, up from 26 in Q1 2025.
  • Funds reported $50M of Tonix Pharmaceuticals stock for Q2 2025, up 487% quarter-over-quarter.
  • 27 funds opened new Tonix Pharmaceuticals positions in Q2 2025 and 6 closed out, a net change of +21 holders.
  • The largest Tonix Pharmaceuticals buyer in Q2 2025 was BlackRock, an estimated $9.19M added.
  • The largest Tonix Pharmaceuticals seller in Q2 2025 was Royal Bank of Canada, an estimated $878K sold.

Based on aggregated 13F filings for Q2 2025.